QuidelOrtho (QDEL) Cash from Operations Growth (3y) (2024 - 2026)
QuidelOrtho (QDEL) Cash from Operations Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | 0.50% |
| 10 | QuidelOrtho | 1.18 Bn | 1.04 Bn | - | -29.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -29.56% |
| Dec 28, 2025 | -30.96% |
| Mar 30, 2025 | -49.22% |
| Sep 29, 2024 | 15.26% |